Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Plos One|August 26, 2014
Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trialSteven A Safren, Katie B Biello, Laura Smeaton, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 24, 2015
Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adultsRupak Shivakoti, Parul Christian, Wei-Teng Yang, et al.
The Journal of Infectious Diseases|December 2, 2015
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained SettingsRupak Shivakoti, Wei-Teng Yang, Sima Berendes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2007
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120Farley Cleghorn, Jean W Pape, Mauro Schechter, et al.
Open Forum Infectious Diseases|July 28, 2022
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden SettingsAmita Gupta, Xin Sun, Sonya Krishnan, et al.
Frontiers in Immunology|November 27, 2020
Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical StudyJorge Sanchez, Elena Gonçalves, Anuska Llano, et al.
AIDS and Behavior|November 10, 2017
Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with MenAlex Carballo-Diéguez, Rebecca Giguere, Curtis Dolezal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2015
Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled TrialKathleen Mulligan, David V Glidden, Peter L Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2017
Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort StudyMark W Tenforde, Ashish Yadav, David W Dowdy, et al.
Plos One|February 27, 2015
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settingsMark W Tenforde, Nikhil Gupte, David W Dowdy, et al.
Pageof 15